|
NDUFB4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.385400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.996300E-02 |
| Normal-vs-Stage2 |
9.165400E-01 |
| Normal-vs-Stage3 |
8.312800E-01 |
| Normal-vs-Stage4 |
4.142200E-01 |
| Stage1-vs-Stage2 |
2.895400E-01 |
| Stage1-vs-Stage3 |
1.102600E-01 |
| Stage1-vs-Stage4 |
1.578040E-02 |
| Stage2-vs-Stage3 |
8.272800E-01 |
| Stage2-vs-Stage4 |
6.838000E-01 |
| Stage3-vs-Stage4 |
3.203000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.017400E-01 |
| Normal-vs-AfricanAmerican |
7.892800E-01 |
| Normal-vs-Asian |
8.758000E-02 |
| Caucasian-vs-AfricanAmerican |
7.186800E-01 |
| Caucasian-vs-Asian |
3.656800E-01 |
| AfricanAmerican-vs-Asian |
2.979800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.272000E-02 |
| Normal-vs-Female |
8.107700E-02 |
| Male-vs-Female |
2.75520000003748E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.068600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.075800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.094200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.787000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.617000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.807800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.461200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.263200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.679600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.111800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.116800E-01 |
| Normal-vs-Grade 2 |
1.225380E-01 |
| Normal-vs-Grade 3 |
6.959200E-01 |
| Normal-vs-Grade 4 |
8.717200E-01 |
| Grade 1-vs-Grade 2 |
8.376200E-01 |
| Grade 1-vs-Grade 3 |
8.442600E-01 |
| Grade 1-vs-Grade 4 |
8.036000E-01 |
| Grade 2-vs-Grade 3 |
2.540600E-01 |
| Grade 2-vs-Grade 4 |
3.263400E-01 |
| Grade 3-vs-Grade 4 |
9.002200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.456600E-01 |
| Normal-vs-ccB subtype |
2.371200E-01 |
| ccA subtype-vs-ccB subtype |
3.105200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.064600E-01 |
| Normal-vs-N1 |
5.274600E-01 |
| N0-vs-N1 |
4.524400E-01 |
|
|
